Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Manual Resuscitators Market Size & Share 2026-2035
Report ID: GMI14043
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Manual Resuscitators Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Manual Resuscitators Market Size
The Manual Resuscitators Market was valued at USD 578 million in 2025, advanced to USD 627 million in 2026, is projected to expand at an 8.4% CAGR (2026–2035), and is expected to reach USD 1.30 billion by 2035.
Manual Resuscitators Market Key Takeaways
Market Leader: Laerdal Medical led with over 14% market share in 2025.
Leading Players: Top 5 players in this market include Laerdal Medical, Teleflex Incorporated, AirLife (a Vyaire Medical brand), Fisher & Paykel Healthcare, Medline Industries, which collectively held a market share of 47% in 2025.
The manual resuscitators market comprises portable, hand-operated positive-pressure ventilation devices used in emergency and clinical care, including self-inflating bag-valve-mask assemblies, neonatal T-piece devices, and flow-inflating formats. Growth reflects respiratory and cardiac emergency demand, wider adoption of single-use devices under infection-control protocols, and expanding neonatal and pediatric critical-care infrastructure. Product mix is increasingly shaped by the balance between disposable convenience and premium reusable performance.
GMI Analyst View
Based on discussions with clinical supply chain leaders, the manual resuscitators market generated USD 460 million in revenue in 2022, confirming the sector's sustained demand buildup and establishing the pre-forecast-period trajectory that now underpins the market's 2026–2035 growth outlook.
Manual Resuscitators Market Trends, Growth Drivers & GMI Forecast Outlook
Emergency-care demand, neonatal care investment, and the migration toward disposable formats are reshaping purchasing patterns. The forecast is supported by recurrent clinical-use requirements and replacement cycles, although fiscal constraints and uneven care infrastructure limit conversion of clinical need into realized procurement in lower-resource settings.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Facility deliveries and neonatal program expansion create recurring device demand because each care setting requires appropriately sized and immediately available ventilation equipment. Procurement therefore extends beyond initial NICU commissioning to replacement, stock management, and emergency-readiness requirements. This creates a durable demand base for neonatal devices in markets expanding delivery-room capability and clinical standardization.
Pre-hospital care provides a separate replacement cycle from hospital purchasing. U.S. EMT and paramedic employment is projected to grow 5% from 2024 to 2034, with approximately 19,000 annual job openings anticipated on average across the decade [5]U.S. Bureau of Labor Statistics. "EMTs and Paramedics: Occupational Outlook Handbook." bls.gov. Fleet renewal and standardized emergency kits support recurring demand for BVM assemblies, while parallel emergency-care modernization broadens institutional purchasing across developed and urbanizing healthcare systems.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Healthcare-system constraints create a material divide between clinical need and commercial purchasing. In many lower-income settings, health ministries must prioritize across acute-care infrastructure, staffing, medicines, and emergency equipment. As a result, manual resuscitator tenders often emphasize affordability and broad availability, limiting the pace of migration toward higher-specification formats.
Material costs add a second pressure point. Silicone supports durability and premium reusable positioning, but the validation burden and qualified-input requirements can weaken its competitiveness in price-sensitive tenders. Manufacturers seeking to move upmarket must therefore manage product performance, regulatory documentation, and tender economics without allowing a premium mix to erode addressable demand.
GMI Analyst View
We see the market separating into two durable commercial channels. High-income health systems are institutionalizing disposable purchasing around compliance, infection control, and operational simplicity, while constrained public tenders continue to favor economical PVC formats. Portfolio discipline across these channels will determine which manufacturers protect margins without surrendering tender volume.
Manual Resuscitators Market Segment Analysis
By Product Type
The Manual Resuscitators Market is led by self-inflating resuscitators, which generated USD 376 million in 2025 and are projected to generate USD 780 million by 2035. Their broad clinical applicability across emergency departments, EMS fleets, operating suites, and delivery rooms gives the category the largest institutional procurement base. Disposable adoption strengthens recurring consumption, while the installed need for readily deployable BVM devices limits exposure to discretionary capital-spending cycles.
T-piece resuscitators are projected to account for 27% of market revenue by 2035 and expand at an 11.7% CAGR (2026–2035). Their pressure-controlled delivery supports neonatal use cases where consistency and clinical protocol adherence matter most. NICU additions and delivery-room upgrades are consequently shifting demand toward T-piece systems in markets increasing neonatal-care capacity.
Flow-inflating resuscitators represented 15% of revenue in 2025 and are expected to grow at a 6.9% CAGR (2026–2035). Their role remains concentrated in anesthesia and controlled clinical environments because effective use depends on specialized operator familiarity. The category retains clinical relevance where pressure and oxygen control are valued, but its narrower setting base limits expansion relative to more broadly deployable formats.
By Modality
Disposable resuscitators generated USD 358 million in 2025 and are expected to command 70% of market revenue by 2035. Hospitals and EMS providers increasingly favor single-use products to avoid reprocessing validation, simplify inventory handling, and reduce cross-contamination concerns. This transition supports predictable replenishment demand and strengthens the commercial importance of compliant, ready-to-use kits.
Reusable resuscitators are projected to generate USD 390 million by 2035 and grow at a 5.9% CAGR (2026–2035). The segment remains relevant where organizations have robust reprocessing capability and value silicone durability over the lifecycle of the device. Its position is strongest in specialized clinical settings and procurement environments where service-life economics outweigh the operational advantages of single-use formats.
By Material
PVC resuscitators generated USD 278 million in 2025 and are projected to retain 48% of market revenue by 2035. The material remains central to cost-efficient disposable devices, especially where hospitals and government systems need to expand infection-control capability without materially increasing per-unit spend. High supplier availability also keeps PVC closely aligned with large-scale tender and private-label procurement.
Silicone resuscitators are projected to capture 40% of revenue by 2035 and advance at a 10.9% CAGR (2026–2035). Demand is supported by durability, latex-free performance, and use in premium reusable and neonatal formats. Higher-specification hospital systems increasingly use material choice as part of clinical procurement requirements, favoring manufacturers that can support validated quality and reliable supply.
Rubber resuscitators generated USD 116 million in 2025 and are forecast to grow at a 3.0% CAGR (2026–2035). The category is being displaced by silicone in reusable devices and PVC in disposable products. Latex sensitivity concerns and evolving institutional specifications reduce its relevance in high-income healthcare systems, leaving demand increasingly concentrated in cost-sensitive markets.
By Patient Type
Adult resuscitators generated USD 318 million in 2025 and are projected to account for 52% of revenue by 2035. Emergency cardiopulmonary events, hospital crash-cart requirements, and EMS procurement maintain the adult segment's large volume foundation. Even as neonatal products expand faster, adult formats remain indispensable across routine emergency-readiness protocols.
Pediatric resuscitators held 27% of market revenue in 2025 and are projected to generate USD 351 million by 2035. Dedicated sizing requirements are increasing procurement of purpose-built pediatric devices rather than adapted adult formats. This supports more complete device portfolios within hospitals and emergency-care systems as pediatric treatment standards become more consistently implemented.
Neonatal resuscitators are projected to generate USD 273 million by 2035 and grow at a 10.1% CAGR (2026–2035). Delivery rooms and NICU beds require appropriately sized BVM or T-piece devices, tying demand directly to maternal and neonatal-care capacity. The segment benefits from care-standardization programs that make neonatal ventilation readiness a routine part of facility equipment planning.
By Application
Cardiopulmonary arrest management generated USD 301 million in 2025 and is expected to retain 50% of market revenue by 2035. BVM devices remain foundational to emergency ventilation across EMS, emergency departments, and intensive-care settings. Recertification requirements, stock replacement, and protocol-driven preparedness sustain demand beyond episodic acute-care utilization.
The COPD application segment is projected to reach USD 390 million by 2035 and expand at a 9.2% CAGR (2026–2035). Acute exacerbations increase the need for immediate ventilatory support in hospital and pre-hospital settings. This favors rapid-deployment products that are compatible with emergency workflows and high-flow oxygen requirements.
Other applications represented 20% of market revenue in 2025 and are projected to generate USD 260 million by 2035. Trauma care, procedural recovery, and anesthesia-related airway support create a diversified demand base across surgical theaters, interventional suites, and trauma bays. These settings support stable purchasing because device availability is tied to clinical protocol and procedure preparedness.
By End Use
Hospitals generated USD 335 million in 2025 and are projected to account for 55% of market revenue by 2035. Their purchasing spans emergency departments, ICUs, operating rooms, delivery suites, and ward-level crash carts, creating multi-department demand. Infection-control committees are increasingly influential in determining the disposable-versus-reusable mix, making hospital policy a decisive commercial lever.
Ambulatory surgical centers are projected to generate USD 325 million by 2035 and grow at a 9.8% CAGR (2026–2035). ASC expansion creates new demand for compliant airway-management equipment, while streamlined operating models favor disposable products that remove reprocessing complexity. The segment offers manufacturers an avenue to serve procedure-intensive settings outside traditional hospital procurement.
Other end-use settings generated USD 116 million in 2025 and are projected to hold 20% of revenue by 2035. EMS, transport services, home respiratory care, and disaster-preparedness programs require manual resuscitators as immediate backup ventilation tools. Their demand is driven by fleet standards, stockpiling policies, and emergency-readiness requirements rather than a single care-delivery channel.
GMI Analyst View
We believe the decisive competitive shift is toward material and format differentiation rather than product-type breadth alone. T-piece systems address neonatal investment cycles, silicone reinforces premium reusable positioning, and PVC supports disposable scale. Manufacturers must choose a coherent mix architecture instead of attempting to compete indiscriminately across conflicting price and performance tiers.
Manual Resuscitators Market Regional Analysis
North America Manual Resuscitators Market Analysis
The Manual Resuscitators Market in North America generated USD 191 million in 2025 and is projected to account for 29% of global revenue by 2035. EMS modernization, hospital infection-control policy, and replacement purchasing across emergency departments and ASCs underpin demand. The region's mature clinical infrastructure also supports higher adoption of compliant disposable and premium formats.
U.S.
The U.S. generated USD 158.5 million in 2025 and is projected to reach USD 307 million by 2035. A mature hospital procurement base, standardized EMS fleets, and strong disposable-format adoption support its position as the largest national contributor. Risk-management practices and organized emergency-care purchasing reinforce recurring demand.
Canada
Canada is projected to reach USD 70 million by 2035 and grow at a 7.9% CAGR (2026–2035). Provincial equipment renewal, population aging, and modernization of paramedic protocols support demand. Acute-care facilities are also increasing use of disposable products as supply-chain and infection-control requirements evolve.
Europe Manual Resuscitators Market Analysis
Europe held 25% of revenue in 2025 and is projected to generate USD 299 million by 2035. The Manual Resuscitators Market in the region is shaped by demanding device-validation requirements, established hospital networks, and aging demographics. Product mix is moving toward high-specification silicone and disposable devices that can satisfy clinical governance and procurement standards.
Germany
Germany is projected to generate USD 59 million by 2035 and expand at a 7.5% CAGR (2026–2035). High procurement standards and silicone premiumization support demand, while its regulatory and clinical specifications influence broader regional qualification expectations.
UK
The UK generated USD 23 million in 2025 and is expected to grow at a 7.2% CAGR (2026–2035). NHS procurement cycles and private-sector demand sustain purchasing, while stable device-approval frameworks support continued adoption of disposable BVM formats.
France
France held 14% of European revenue in 2025 and is projected to generate USD 41 million by 2035. National hospital procurement structures and established critical-care capacity support steady demand, with clinical governance progressively favoring disposable airway-contact devices.
Italy
Italy generated USD 15.8 million in 2025 and is forecast to grow at a 7.0% CAGR (2026–2035). Public-budget constraints slow procurement modernization despite substantial clinical need, limiting the pace of premium-product adoption relative to more fiscally flexible European markets.
Spain
Spain is projected to generate USD 26 million by 2035 and represented 9% of European revenue in 2025. Regional health-system procurement drives demand, while accreditation requirements and healthcare-infrastructure modernization support gradual adoption of clinical-standard devices.
Netherlands
The Netherlands held 8% of European revenue in 2025 and is projected to generate USD 23 million by 2035. Dense hospital infrastructure and a sophisticated distribution network support high specification purchasing, particularly for silicone formats used by academic medical centers.
Rest of Europe
Rest of Europe is projected to hold 24% of European revenue by 2035 and grow at an 8.6% CAGR (2026–2035). Hospital infrastructure investment across Central and Eastern Europe is creating new demand as facilities upgrade toward EU-aligned clinical equipment standards.
Asia Pacific Manual Resuscitators Market Analysis
The Manual Resuscitators Market in Asia Pacific generated USD 174 million in 2025 and is projected to account for 36% of global revenue by 2035. NICU additions, hospital-network expansion, and broader adoption of neonatal-care protocols are creating first-time institutional demand. Growth is concentrated in major national markets and is rebalancing the global geographic mix.
China
China generated USD 62.6 million in 2025 and is projected to retain 36% of Asia Pacific revenue by 2035. Hospital tier expansion and provincial infrastructure investment support procurement of emergency and neonatal equipment. Domestic disposable-device manufacturing also strengthens China's role in supply for both local and export markets.
Japan
Japan is projected to generate USD 64 million by 2035 and grow at a 6.3% CAGR (2026–2035). The market is mature, with dense existing hospital and EMS infrastructure. Demand is therefore oriented toward specification upgrades and reusable silicone formats rather than major volume expansion.
India
India is projected to account for 22% of Asia Pacific revenue by 2035 and expand at a 14.5% CAGR (2026–2035). National neonatal-care procurement and NICU expansion are widening facility-level equipment deployment. High-volume public tenders coexist with a growing private-hospital channel that increasingly demands internationally aligned clinical specifications.
South Korea
South Korea generated USD 15.7 million in 2025 and is expected to grow at an 8.2% CAGR (2026–2035). Advanced healthcare investment and a competitive medical-device production base support both domestic demand and participation in the global disposable-resuscitator supply chain.
Australia
Australia generated USD 13.9 million in 2025 and is projected to grow at a 6.8% CAGR (2026–2035). Replacement cycles in hospitals and EMS systems anchor demand, while high clinical standards support adoption of premium silicone and disposable formats.
Rest of APAC
Rest of APAC is projected to represent 15% of regional revenue by 2035 and grow at a 13.1% CAGR (2026–2035). Southeast Asian hospital construction and universal-health-coverage programs are increasing first-time purchases of emergency and neonatal-care equipment across expanding care networks.
Latin America Manual Resuscitators Market Analysis
The Manual Resuscitators Market in Latin America is projected to generate USD 91 million by 2035 and expand at an 8.6% CAGR (2026–2035). Public emergency-equipment standardization and private-hospital expansion sustain demand, although economic volatility and fragmented purchasing environments temper adoption of premium formats outside the largest national markets.
Brazil
Brazil generated USD 18.4 million in 2025 and is projected to account for 51% of Latin American revenue by 2035. Public procurement and maternal-and-infant health programs support demand, while the country's scale reinforces its role as the region's central medical-device purchasing market.
Mexico
Mexico is projected to generate USD 28 million by 2035 and grow at an 8.8% CAGR (2026–2035). Private-hospital expansion complements public procurement modernization, supporting demand for both premium BVM formats and cost-competitive tender products.
Argentina
Argentina represented 10% of Latin American revenue in 2025 and is forecast to grow at a 5.5% CAGR (2026–2035). Fiscal constraints and currency volatility limit procurement modernization and discourage longer-term purchasing commitments for imported clinical equipment.
Rest of Latin America
Rest of Latin America is projected to generate USD 10.2 million by 2035 and advance at a 6.6% CAGR (2026–2035). Mixed public-private purchasing environments support demand, but fragmented distribution and variable regulatory conditions moderate market formalization.
Middle East & Africa (MEA) Manual Resuscitators Market Analysis
The Manual Resuscitators Market in Middle East & Africa (MEA) generated USD 29 million in 2025 and is projected to reach USD 65 million by 2035. Gulf healthcare-infrastructure investment supports equipment upgrades and emergency stockpiling, while infrastructure gaps and constrained budgets continue to limit commercial-market realization across many African and North African countries.
Saudi Arabia
Saudi Arabia accounted for 28% of MEA revenue in 2025 and is projected to generate USD 24 million by 2035. Centralized public procurement and healthcare-capital programs support the country's leading role in regional equipment upgrades and clinical-standard adoption.
UAE
The UAE is projected to generate USD 19.5 million by 2035 and grow at a 10.7% CAGR (2026–2035). Private-hospital expansion, medical-tourism investment, and accreditation-led equipment standards support demand for higher-specification products.
South Africa
South Africa generated USD 4.9 million in 2025 and is expected to advance at a 5.5% CAGR (2026–2035). Private hospital groups sustain premium-format demand, while public-sector resource constraints restrict broader modernization despite substantial clinical need.
Rest of MEA
Rest of MEA represented 31% of regional revenue in 2025 and is forecast to grow at a 3.8% CAGR (2026–2035). Budget limitations, fragmented supply chains, and underdeveloped hospital infrastructure constrain commercial procurement, leaving many markets dependent on aid, emergency-health kits, and nongovernmental purchasing channels.
GMI Analyst View
We view Asia Pacific's growth position as structural, supported by neonatal-care buildout and first-time institutional procurement rather than temporary price displacement. North America and Europe are increasingly mix-led markets. The resulting global opportunity rewards companies that can pair cost-effective scale for emerging-market tenders with premium clinical specification for high-income channels.
Manual Resuscitators Market Share & Competitive Landscape
The Manual Resuscitators Market share structure is moderately concentrated, with the five leading companies collectively accounting for 47% of global revenue in 2025. The balance is distributed across regional manufacturers, OEM specialists, and cost-competitive suppliers, particularly in Asia Pacific. Commodity BVM categories remain comparatively accessible, while regulatory compliance, clinical qualification, and distribution depth create greater differentiation in premium segments.
Laerdal Medical held a 14% market share in 2025. Its global distribution reach, emergency-care brand recognition, clinical-training ecosystem, and coverage across disposable BVM, silicone reusable, and neonatal formats give it broad procurement exposure. The company is particularly well positioned where device availability, clinical familiarity, and training integration influence account retention.
Teleflex Incorporated held an 11% market share in 2025. Its Anesthesia & Emergency Care portfolio and established hospital supply-chain relationships provide cross-selling leverage across hospital, EMS, and ASC customers. This broader respiratory and airway-management presence supports participation in institutional accounts where vendor consolidation and portfolio breadth affect purchasing decisions.
AirLife (a Vyaire Medical brand) held a 9% market share in 2025. Its positioning in cost-efficient disposable BVM products aligns with the shift toward single-use formats across hospital and emergency-care procurement. Broad adult, pediatric, and neonatal coverage supports its participation in high-volume institutional replacement demand.
Fisher & Paykel Healthcare maintains differentiated positioning through respiratory-consumables expertise and Asia Pacific market penetration. Medline Industries benefits from its established distribution infrastructure and group purchasing organization relationships in U.S. hospital and long-term-care channels. Together, established global players, regional specialists, and OEM suppliers create competitive intensity across both premium and commodity product tiers.
Mercury Medical and Flexicare Medical hold specialized positions in North American and European airway-management markets. Besmed Health Business Corp., GaleMed Corporation, and HSINER Co., Ltd. support global private-label and distributor supply from Taiwan's OEM and ODM base. ANGIPLAST Pvt. Ltd., NEOKRAFT Medical Pvt. Ltd., Romsons Group of Industries, and BOENMED address emerging-market tenders where price, domestic sourcing, and dependable supply are central to product selection.
Recent Industry Developments
Laerdal Medical - FDA 510(k) clearance for The BAG manual resuscitator: Laerdal Medical received FDA 510(k) clearance for The BAG manual resuscitator and accessories on November 24, 2025, under product code BTM [6]U.S. Food and Drug Administration. "510(k) Premarket Notification K251631." accessdata.fda.gov. The clearance covers a single-use self-inflating manual resuscitator available in adult, pediatric, and neonatal sizes. The development reflects continued investment in disposable, clinically validated formats as institutional purchasing shifts toward products that simplify infection-control and emergency-readiness workflows.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →